Pure red cell aplasia to respond to treatments with rituximab and tacrolimus. Pure red cell aplasia Pure red cell aplasia (PRCA) or erythroblastopenia refers to a type of anemia affecting the precursors to red blood cells but not to white blood cells. In PRCA, the bone marrow ceases to produce red blood cells. There are multiple etiologies that can cause PRCA. The condition has been first described by Paul Kaznelson in 1922. Signs and symptoms may include: Causes of PRCA include: PRCA is considered an autoimmune disease as it will respond to immunosuppressant treatment such as cyclosporin in many patients, though this approach is
Neonatal red cell transfusion baby (e.g. wristband). Paedipacks are multiple aliquots made from one adult blood donation. By using paedipacks, the baby is exposed to blood from fewer blood donors. ABO blood grouping and screening for antibodies in neonates differs from blood grouping in adults and older children. Any antibodies detected are the mother's antibodies rather than the baby's. Therefore, any donor blood given to the baby must be ABO and D compatible with both mother and baby; and antigen-negative for any clinically significant maternal antibodies. Necrotising enterocolitis may occur after a red cell transfusion in neonates, although there is an association between the